nNOSμ-deficient skeletal muscle exhibits decreased resistance to exercise-induced fatigue. by Justin M. Percival (376431)

SHIP-1 decreases NOD2-induced NF-κB activation in epithelial cells. by Claude Condé (150801)

Adiponectin-induced Irak3 plays an important role in rosiglitazone-mediated decrease of Mcp1. by Maarten Hulsmans (181118)

Sustained expression of radmis results in decreased cell proliferation and increased cell-cycle exit of NSPCs. by Takahito Yumoto (481671)

ATRA decreases mRNA expression of HO-1, GCLM and x-CT and lowers GSH level in BTZ-treated cells. by A. L. Furfaro (2587792)

Procaspase 8 inducing drugs decrease total HIV DNA <i>ex vivo</i>. by Rahul Sampath (4117297)

B-RAF inhibitor PLX4720 decreased hERG currents in rhabdomyosarcoma RD cells. by Tatsiana Pakladok (311653)

Astrocytes increase contact with vessels and expression of AQP4 following Mtb infection, which is decreased in cytosis⁺ animals. by Amanda S. Latham (12093638)

“…Representative images of the frontal cortex (A–D), cerebral nuclei (G–J), brain stem (M–P), thalamus (S–V), and hippocampus (Y–BB) 15 days post-infection are shown. …”

IUGR pups have decreased cell proliferation at age P14 compared to sham controls. by Camille M. Fung (844334)

“…IUGR decreased the number of Ki-67⁺ cells at P14 only compared to shams (n = 5 for each treatment group, p = 0.04, representative micrographs from P14 mice are shown as the lower panel of A). …”

Treatment of NCI-H1975 cell-transplanted mice with erastin showed a tendency of sensitization to X-ray irradiation with a decrease in glutathione concentration. by Yuki Shibata (5094866)

Addition of ATO decreases rapamycin-induced AKT activation <i>in</i><i>vivo</i>. by Cynthia Guilbert (504573)

HAART does not affect CTLA-4 expression, but significantly decreases CD39 expression in Tregs. by Pietro Presicce (144163)

HAART decreased enhanced expression of cell cycling markers in Tregs from HIV-infected subjects. by Pietro Presicce (144163)

Grand mean average waveforms, including amplitude (µV) from midline regions for the “increase” and “decrease” instructional set for men and women. by Elyse K. T. Gardener (478203)

“…<p>Grand mean average waveforms, including amplitude (µV) from midline regions for the “increase” and “decrease” instructional set for men and women.…”

Decreased proportions of MOMA⁺ MZ macrophages during infection with <i>Salmonella</i>. by Kristin L. Rosche (754117)

Gene ontology biological processes overrepresented among genes exhibiting decreased expression in human psoriasis. by William R. Swindell (175427)

“…<p>A total of 3540 transcripts were identified as significantly decreased in psoriatic plaques obtained from human patients relative to normal skin obtained from control subjects (FDR-adjusted P<0.05 and log₂-transformed fold-change less than -0.50). …”

TGF-β₁ increases proliferation but decreases AP activity in cultured osteoblasts. by Sabrina Ehnert (359631)

“…<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) of hra TGF-β₁. (A) SRB staining of surface proteins showed that TGF-β₁ dose-dependently increased proliferation of osteoblasts. …”

Time-dependent network state variability decreases near seizure onset during preseizure periods. by Adrià Tauste Campo (5066141)

The ratio between the bias in the naïve SI and shuffle SI decreases with tuning specificity, but not with sample size. by Liron Sheintuch (12078310)

“…Data pooled from N = 9 simulations, each corresponding to behavioral data from a different mouse. (B) The bias ratio (mean ± SEM) decreases as a function of the true SI for a sample size of 1 minute (blue), 5 minutes (cyan) and 20 minutes (green). …”

Reduction of SIRT1 during DNA damage decreases the number of silent clones that have methylation. by Heather M. O'Hagan (271283)

“…One representative bisulfite sequenced clone is presented for each HSVTK silent clone. (B) A dot plot of the mean number of CpGs methylated per HSVTK silenced clone from either un-siRNA treated cells (untreated) (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000155#pgen-1000155-g005" target="_blank">Figure 5D & E</a>), non-target siRNA treated cells (NT), or SIRT1 siRNA treated cells (SIRT1). …”